M Massi-Benedetti - Clinical therapeutics, 2003 - Elsevier Background: Sulfonylureas (SUs) have been used for many years as first-line
therapy for patients with type 2 diabetes mellitus whose blood glucose levels
have not been effectively controlled by diet and exercise alone. ... Cited by 31 - Related articles - All 4 versions
S Martin, H Kolb, J Beuth, R Leendert, B … - Diabetologia, 2003 - Springer Aims/hypothesis. Our study compared the effects of glimepiride or glibenclamide
treatment on body weight over 12 months of treatment in patients with Type 2
diabetes in routine outpatient practice. Methods. This new retrospective ... Cited by 16 - Related articles - BL Direct - All 3 versions
MU Kabadi, UM Kabadi - Clinical therapeutics, 2004 - Elsevier Methods: This 24-week, open-label, controlled trial was conducted at the
Division of Endocrinology and Metabolism, Veterans Affairs Medical Center
(Phoenix, Arizona). Study participants were aged 32 to 75 years and had ... Cited by 14 - Related articles - All 3 versions
UM Kabadi, M Kabadi - Diabetes research and clinical practice, 2006 - Elsevier SC insulin Novolog Mix [70/30], pre-supper was initiated in 12 subjects on
metformin, 14 subjects on glimepiride, and 12 subjects receiving both drugs,
with HbA1C > 7.5% and eight subjects receiving placebo. Insulin dose was ... Cited by 11 - Related articles - All 11 versions
GI Uwaifo, RE Ratner - The American Journal of Cardiology, 2007 - Elsevier Cardiovascular disease (CVD) burden remains the predominant cause of mortality
and morbidity in the United States and in most of the developed world. The
ongoing twin epidemics of obesity and type 2 diabetes mellitus provide a ... Cited by 9 - Related articles - All 32 versions
T Hamaguchi, T Hirose, H Asakawa, Y Itoh, … - Diabetes research and clinical practice, 2004 - Elsevier Multicentric study was conducted to evaluate the efficacy of glimepiride in the
oral hypoglycemic agents therapy of type 2 diabetic patients treated with
glibenclamide so far, and to claim an adequate use of this new generation ... Cited by 2 - Related articles - All 3 versions
H Stingl, M Roden - Wiener Klinische Wochenschrift, 2004 - Springer Zusammenfassung. Die Prävention und Behand- lung des Typ-2-Diabetes mellitus
(T2DM) und des meta- bolischen Syndroms stellen eine große klinische Heraus-
forderung dar, da wirksame therapeutische Strategien wie fettarme Diät und ... Cited by 1 - Related articles - BL Direct - All 2 versions
G Muller - Current Medicinal Chemistry-Immunology, Endocrine & …, 2005 - ingentaconnect.com Abstract: During the past 10 years a multitude of clinical and observational
studies have confirmed the efficacy of the antidiabetic drug, glimepiride, in
lowering fasting and postprandial blood glucose in lean and obese type 2 ... Related articles - BL Direct
- ►ksu.edu.sa [PDF] OM Ibrahim, GA El-Azab, NE El-Ashmawy, NM …, 2009 - repository.ksu.edu.sa Aspirin as Adjuvant Therapy for Diabetic Patients Treated ... Osama M. Ibrahim
1 , Gamal A. El-Azab 1 , Nahla E. El-Ashmawy 2 , ... Nasrat M. Ayad 3 , and
Haiam M. El-Serafy 1 ... 1 Department of Clinical Pharmacy, Faculty of ... Related articles - View as HTML
